Table 1. Positive results of an enzyme-linked immunotransfer blot (EITB) assay and a monoclonal antibody–based enzyme-linked immunosorbent assay (Ag-ELISA) for serum and cerebrospinal fluid (CSF) specimens from patients with intraparenchymal neurocysticercosis.
Positive results, proportion (%) | ||||
---|---|---|---|---|
Assay, specimen | Patients with viable cysts |
P a | Patients with calcified cysts only |
P a |
EITB | .125 | NS | ||
Serum | 41/41 (100) | 7/7 (100) | ||
CSF | 37/41 (90.2) | 6/7 (85.7) | ||
Ag-ELISA | .219 | NS | ||
Serum | 18/30 (60) | 1/7 (14.3) | ||
CSF | 22/30 (73.3) | 2/7 (28.6) |
By the McNemar test.